 - On a stable dose of anti-hyperglycemic agents AHA, including oral hypoglycemics OAs, non-insulin injectables e.g. GLP-1 or insulin therapy 2 months prior to screening; Note: the definition of stable includes subjects who routinely self-adjust insulin based on in the moment SMBG values. Stable does not include actual diabetes therapy changes e.g. new oral medications, initiating insulin or changing insulin regimen, insulin to carb ratio changes or basal to bolus insulin progression 